Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial

Gallwitz, B.; Rosenstock, J.; Patel, S.; von Eynatten, M.; Hehnke, U.; Mehlburger, L.; Dugi, K. A.; Woerle, H. -J.

dc.contributor.author	Gallwitz, Baptist
dc.date.accessioned	2015-04-16T09:50:56Z
dc.date.available	2015-04-16T09:50:56Z
dc.date.issued	2015
dc.identifier.issn	1462-8902
dc.identifier.uri	http://hdl.handle.net/10900/62815
dc.language.iso	en	en
dc.publisher	Wiley - Blackwell	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/dom.12419	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150402110707_00058	de_DE
utue.publikation.seiten	276-284	de_DE
utue.personen.roh	Gallwitz, B.
utue.personen.roh	Rosenstock, J.
utue.personen.roh	Patel, S.
utue.personen.roh	von Eynatten, M.
utue.personen.roh	Hehnke, U.
utue.personen.roh	Mehlburger, L.
utue.personen.roh	Dugi, K. A.
utue.personen.roh	Woerle, H. -J.
dcterms.isPartOf.ZSTitelID	Diabetes Obesity & Metabolism	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE